List of works - Shlomo Melmed

A Pituitary Society update to acromegaly management guidelines

scientific article published on 20 October 2020

A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegaly

scientific article

A structural and functional acromegaly classification

scientific article

Acromegaly clinical trial methodology impact on reported biochemical efficacy rates of somatostatin receptor ligand treatments: a meta-analysis

scientific article

Acromegaly pathogenesis and treatment

scientific article

Adult mortality or morbidity is not increased in childhood-onset growth hormone deficient patients who received pediatric GH treatment: an analysis of the Hypopituitary Control and Complications Study (HypoCCS).

scientific article

Angiogenesis in endocrine tumors.

scientific article published on October 2003

CEBPD Suppresses Prolactin Expression and Prolactinoma Cell Proliferation ⬇️

scientific article published on October 6, 2011

Clinical factors associated with biochemical adrenal-cortisol insufficiency in hospitalized patients

scientific article

Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).

scientific article

Clinical review 154: The role of pharmacotherapy in perioperative management of patients with acromegaly

scientific article

Clinical, quality of life, and economic value of acromegaly disease control ⬇️

scientific article published on September 1, 2011

Current status and future opportunities for controlling acromegaly

scientific article

Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease

scientific article

EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas

scientific article published on 21 November 2011

ErbB receptor-driven prolactinomas respond to targeted lapatinib treatment in female transgenic mice

scientific article

Expert consensus document: A consensus on the medical treatment of acromegaly

scientific article

Functional role of estrogen in pituitary tumor pathogenesis

scientific article

Genomic Characterization of Human and Rat Prolactinomas ⬇️

scientific article published on May 25, 2012

Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations

scientific article

Growth hormone in the tumor microenvironment

scientific article published on 01 November 2019

HER2/ErbB2 receptor signaling in rat and human prolactinoma cells: strategy for targeted prolactinoma therapy.

scientific article

In vivo time-lapse imaging delineates the zebrafish pituitary proopiomelanocortin lineage boundary regulated by FGF3 signal

scientific article

Lineage-Specific Restraint of Pituitary Gonadotroph Cell Adenoma Growth ⬇️

scientific article published on March 25, 2011

Mechanisms for pituitary tumorigenesis: the plastic pituitary

scientific article

Meta-analysis on the effects of octreotide on tumor mass in acromegaly

scientific article (publication date: 2012)

Minireview: Neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules

scientific article

Molecular targets in pituitary tumours

scientific article published on April 2004

Multidisciplinary management of acromegaly: A consensus

scientific article published on 10 September 2020

Optimizing control of acromegaly: integrating a growth hormone receptor antagonist into the treatment algorithm

scientific article published on October 2003

PPAR-gamma receptor ligands: novel therapy for pituitary adenomas ⬇️

scientific article published on May 1, 2003

PTTG1 attenuates drug-induced cellular senescence

scientific article

Pathogenesis and Diagnosis of Growth Hormone Deficiency in Adults

scientific article published on 01 June 2019

Pituitary Magnetic Resonance Imaging for Sellar and Parasellar Masses: Ten-Year Experience in 2598 Patients ⬇️

scientific article published on April 6, 2011

Pituitary adenoma growth: a model for cellular senescence and cytokine action

scientific article

Pituitary somatostatin receptor signaling

scientific article

Pituitary tumor transforming gene-null male mice exhibit impaired pancreatic beta cell proliferation and diabetes

scholarly article

Pituitary tumor transforming gene: an update

scientific article

Pituitary tumor-transforming gene 1 regulates the patterning of retinal mosaics

scientific article

Pituitary tumors

scientific article

Pituitary-Tumor Endocrinopathies

scientific article published on 01 March 2020

Prospective Evaluation of Incidental Pituitary Imaging Findings in the Sella Turcica

scientific article published on 29 November 2020

Pyridoxal phosphate inhibits pituitary cell proliferation and hormone secretion

scientific article

Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension

scientific article

SAGIT®: clinician-reported outcome instrument for managing acromegaly in clinical practice--development and results from a pilot study

scientific article

STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion

scientific article

Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes

scientific article

Single-surgeon fully endoscopic endonasal transsphenoidal surgery: outcomes in three-hundred consecutive cases

scientific article

Subclinical hyperfunctioning pituitary adenomas: the silent tumors

scientific article

Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor ⬇️

scientific article published on May 2, 2011

The endocrine tumor summit 2008: appraising therapeutic approaches for acromegaly and carcinoid syndrome

scientific article

Zebrafish usp39 mutation leads to rb1 mRNA splicing defect and pituitary lineage expansion

scientific article

List of works by Shlomo Melmed

A Pituitary Society update to acromegaly management guidelines

A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegaly

A structural and functional acromegaly classification

Acromegaly clinical trial methodology impact on reported biochemical efficacy rates of somatostatin receptor ligand treatments: a meta-analysis

Acromegaly pathogenesis and treatment

Adult mortality or morbidity is not increased in childhood-onset growth hormone deficient patients who received pediatric GH treatment: an analysis of the Hypopituitary Control and Complications Study (HypoCCS).

Angiogenesis in endocrine tumors.

CEBPD Suppresses Prolactin Expression and Prolactinoma Cell Proliferation ⬇️

Clinical factors associated with biochemical adrenal-cortisol insufficiency in hospitalized patients

Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).

Clinical review 154: The role of pharmacotherapy in perioperative management of patients with acromegaly

Clinical, quality of life, and economic value of acromegaly disease control ⬇️

Current status and future opportunities for controlling acromegaly

Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease

EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas

ErbB receptor-driven prolactinomas respond to targeted lapatinib treatment in female transgenic mice

Expert consensus document: A consensus on the medical treatment of acromegaly

Functional role of estrogen in pituitary tumor pathogenesis

Genomic Characterization of Human and Rat Prolactinomas ⬇️

Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations

Growth hormone in the tumor microenvironment

HER2/ErbB2 receptor signaling in rat and human prolactinoma cells: strategy for targeted prolactinoma therapy.

In vivo time-lapse imaging delineates the zebrafish pituitary proopiomelanocortin lineage boundary regulated by FGF3 signal

Lineage-Specific Restraint of Pituitary Gonadotroph Cell Adenoma Growth ⬇️

Mechanisms for pituitary tumorigenesis: the plastic pituitary

Meta-analysis on the effects of octreotide on tumor mass in acromegaly

Minireview: Neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules

Molecular targets in pituitary tumours

Multidisciplinary management of acromegaly: A consensus

Optimizing control of acromegaly: integrating a growth hormone receptor antagonist into the treatment algorithm

PPAR-gamma receptor ligands: novel therapy for pituitary adenomas ⬇️

PTTG1 attenuates drug-induced cellular senescence

Pathogenesis and Diagnosis of Growth Hormone Deficiency in Adults

Pituitary Magnetic Resonance Imaging for Sellar and Parasellar Masses: Ten-Year Experience in 2598 Patients ⬇️

Pituitary adenoma growth: a model for cellular senescence and cytokine action

Pituitary somatostatin receptor signaling

Pituitary tumor transforming gene-null male mice exhibit impaired pancreatic beta cell proliferation and diabetes

Pituitary tumor transforming gene: an update

Pituitary tumor-transforming gene 1 regulates the patterning of retinal mosaics

Pituitary tumors

Pituitary-Tumor Endocrinopathies

Prospective Evaluation of Incidental Pituitary Imaging Findings in the Sella Turcica

Pyridoxal phosphate inhibits pituitary cell proliferation and hormone secretion

Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension

SAGIT®: clinician-reported outcome instrument for managing acromegaly in clinical practice--development and results from a pilot study

STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion

Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes

Single-surgeon fully endoscopic endonasal transsphenoidal surgery: outcomes in three-hundred consecutive cases

Subclinical hyperfunctioning pituitary adenomas: the silent tumors

Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor ⬇️

The endocrine tumor summit 2008: appraising therapeutic approaches for acromegaly and carcinoid syndrome

Zebrafish usp39 mutation leads to rb1 mRNA splicing defect and pituitary lineage expansion